Skip to content
  • Monday, 26 October 2026
  • 2:20 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer
Pharmaceutical R&D

ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer

Teuku Ryan Oct 26, 2026 0

The modern therapeutic landscape for advanced ovarian cancer is undergoing a profound structural evolution, driven largely by the clinical maturation…

Read More
With CDC testing paused, clinical labs are stepping up to sustain surveillance and protect timely disease detection.University of Basel Researchers Engineer First Fully Human Synthetic Bone Marrow Model to Advance Cancer Research and Reduce Animal TestingThe Secret Recipe for Life: Earth’s Core Formation Reveals Crucial Chemical BalanceA decade in the making: How functional NAMs are redefining cardiac safety assessment
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule IThe decline in United States drug overdose deaths is not driven by increased naloxone use according to new researchESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancerThe Biological Mystery of Lilliputian Hallucinations and the Discovery of a Mysterious Mushroom Species
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
Lana Keisha Oct 26, 2026
Environmental & Analytical Chemistry
The decline in United States drug overdose deaths is not driven by increased naloxone use according to new research
Abdurrohim Arsyad Oct 26, 2026
Pharmaceutical R&D
ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer
Teuku Ryan Oct 26, 2026
Molecular & Cell Biology
The Biological Mystery of Lilliputian Hallucinations and the Discovery of a Mysterious Mushroom Species
Angie Faith Oct 26, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ